Back to Feed
Fintech
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
Globenewswire·
-Advancing zervimesine clinical development in DLB psychosis – - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management conference call...
Original Source
Globenewswire — www.globenewswire.com